TP53, EGFR, and KRAS mutations in relation to VHL inactivation and lifestyle risk factors in renal-cell carcinoma from central and eastern Europe
Titel:
TP53, EGFR, and KRAS mutations in relation to VHL inactivation and lifestyle risk factors in renal-cell carcinoma from central and eastern Europe
Auteur:
SzymaĆska, K. Moore, L.E. Rothman, N. Chow, W.H. Waldman, F. Jaeger, E. Waterboer, T. Foretova, L. Navratilova, M. Janout, V. Kollarova, H. Zaridze, D. Matveev, V. Mates, D. Szeszenia-Dabrowska, N. Holcatova, I. Bencko, V. Le Calvez-Kelm, F. Villar, S. Pawlita, M. Boffetta, P. Hainaut, P. Brennan, P.